Jun 2, 2016 8:30 am EDT NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program
Feb 8, 2016 8:00 am EST NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients
Dec 22, 2015 8:30 am EST Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Dec 16, 2015 8:30 am EST NEMUS Announces In-Licensing of Cannabidiol (CBD) Derivatives From the University of Mississippi
Oct 5, 2015 8:30 am EDT Nemus Bioscience Partners With Atheln to Accelerate Drug Development Pipelines
Sep 28, 2015 8:30 am EDT Distinguished Physician-Scientist, Dr. Robert N. Weinreb, to Chair the Nemus Ophthalmology Advisory Board